Wegmans Caramel Apple Pecan Topped Brie Cheese -Small - 13 OZ - Clear plastic container with lid UPC: 2-77645-XXXXX-3 (X - varies by weighted price)
Wegmans Food Markets
Products may be contaminated with Listeria monocytogenes
95,018 total recalls in our database
Wegmans Food Markets
Products may be contaminated with Listeria monocytogenes
Zydus Pharmaceuticals (USA)
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Zydus Pharmaceuticals (USA)
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Zydus Pharmaceuticals (USA)
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Defective Container: broken or leaking bottles.
Temperature Abuse
Zydus Pharmaceuticals (USA)
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Zydus Pharmaceuticals (USA)
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Presence of a foreign substance.
Zydus Pharmaceuticals (USA)
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Zydus Pharmaceuticals (USA)
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Presence of a foreign substance.
Atlantic Management Resources
cGMP violations
Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64.
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.
Zydus Pharmaceuticals (USA)
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64.
Zydus Pharmaceuticals (USA)
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.
CGMP deviations: N-nitroso-duloxetine impurity above the proposed interim limit.